Searched for
DRUG ELUTING STENT MARKET SHARE
US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- JAL shares delist from BSE and NSE today: Will its 6.5 lakh shareholders get anything?Jaiprakash Associates shares were delisted from the BSE and NSE on Thursday, marking the closure of one of India's longest-running insolven...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Share of services in exports rises to 48.8% in FY26India's services exports have seen significant growth. The services sector now accounts for nearly half of the country's total exports. Thi...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...
- Firmly committed to building a drug-free Manipur, says CM Yumnam Khemchand SinghManipur is intensifying its fight against drugs. Chief Minister Yumnam Khemchand Singh chaired a meeting to boost intelligence sharing and ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Jaspal Rana, a month before his sudden death, had shared a life lesson in one of his recent Instagram post: 'Life is not a destination...'Indian shooting coach and Asian Games gold medallist Jaspal Rana has passed away at 49. A recent travel video he shared, reflecting on life...
- 'Jab mrityu nishchit ho...': Jaspal Rana's Instagram bio grabs attention. Last posts show Manu Bhaker's coach enjoying pizza & spaghetti in SwitzerlandJaspal Rana Last Instagram Post: Renowned Indian shooter and former Asian Games gold medallist Jaspal Rana passed away at 49 after a cardia...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Indian sailors, ship fined $6 million in Lagos cocaine caseA Nigerian court has convicted 11 Indian sailors and their vessel, MV Aruna Hulya, for cocaine trafficking. Authorities discovered 31.5 kil...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
Load More
